An Academic and Industry Perspective for Accelerating the Development of Oligonucleotide Therapeutics
Anastasia Khvorova, PhD, Professor, RNA Therapeutics Institute, UMass Chan Medical School
#oligonucleotidetherapeutics #rnatherapeutics #translationalresearch
Why this is critically important to the oligonucleotide industry
The development of oligonucleotide therapeutics continues to advance at a rapid pace, with new modalities, delivery strategies, and regulatory pathways shaping the field. In this keynote, Dr. Khvorova will share insights from both academic research and industry practice, highlighting strategies to accelerate the development and translation of oligonucleotide-based medicines.
This is a session designed to give you an understanding of lessons from the lab and commercial development intersect, with a particular focus on oligonucleotide discovery, RNA therapeutics, and translational research. You’ll walk away with critical knowledge on how to navigate the path from concept to clinic efficiently.
How will it help your career?
Discover how to bridge the gap between academic innovation and industrial application with practical perspectives on strategies to advance oligonucleotide therapeutics from early discovery to clinical development. You will learn more about delivery, scalability and translational considerations and how to apply insights from both the academic and industry contexts to help you accelerate your own projects successfully.
Ideal for those working in research and development, oligonucleotide chemistry, RNA therapeutics, translational medicine, and clinical operations. This is your chance to learn from a leader who bridges the academic and industry divide, helping you position your work for success in a rapidly evolving field.
